Regenerative Medicine of Epithelia: Lessons From the Past and Future Goals
Front Bioeng Biotechnol . 2021 Mar 25;9:652214. doi: 10.3389/fbioe.2021.652214. eCollection 2021.
Maurizi E, Adamo D, Magrelli FA, Galaverni G, Attico E, Merra A, Maffezzoni MBR, Losi L, Genna VG, Sceberras V, Pellegrini G.
This article explores examples of successful and unsuccessful regenerative medicine on human epithelia. To evaluate the applications of the first regenerated tissues, the analysis of the past successes and failures addresses some pending issues and lay the groundwork for developing new therapies. Research should still be encouraged to fill the gap between pathologies, clinical applications and what regenerative medicine can attain with current knowledge.
Keywords: clinical applications; cornea; epidermolysis bullosa; epithelia; oral mucosa; regenerative medicine; salivary gland; trachea.
PMID: 33947848 DOI: 10.1038/s41467-021-22779-9
- Newcastle pharmacy experts work with Italian biotech lab to provide access to sight-saving treatment across England
- Holostem Terapie Avanzate begins its transition to a Foundation
- Transgenic Epidermal Cultures for Junctional Epidermolysis Bullosa — 5-Year Outcomes
- Gene therapy for butterfly children: 5-year follow-up published in the New England Journal of Medicine
- Hologene 5: A Phase II/III Clinical Trial of Combined Cell and Gene Therapy of Junctional Epidermolysis Bullosa